Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Utikal
Selma Ugurel

Showing results (251-260 of 490) with videos related to

Pageof 49
Sort By:
Lancet (London, England)|September 22, 2018
MelanomaDirk Schadendorf, Alexander C J van Akkooi, Carola Berking, et al.
Medical Image Analysis|March 20, 2024
CellViT: Vision Transformers for precise cell segmentation and classificationFabian Hörst, Moritz Rempe, Lukas Heine, et al.
Stem Cell Reports|October 3, 2017
An RNAi Screen Reveals an Essential Role for HIPK4 in Human Skin Epithelial Differentiation from iPSCsLionel Larribère, Marta Galach, Daniel Novak, et al.
International Journal of Cancer|August 15, 2018
A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survivalAdi Sharbi-Yunger, Mareike Grees, Gal Cafri, et al.
Frontiers in Immunology|March 2, 2023
Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patientsVera Petrova, Christopher Groth, Rebekka Bitsch, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 30, 2026
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysisGlenn Geidel, Sabrina Bänsch, Laura Adam, et al.
Ebiomedicine|September 3, 2023
Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma - analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIMJan-Malte Placke, Mona Kimmig, Klaus Griewank, et al.
Frontiers in Immunology|June 25, 2024
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse eventsElias A T Koch, Anne Petzold, Edgar Dippel, et al.
Plos One|February 22, 2014
Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cellsWiebke K Peitsch, Yvette Doerflinger, Reiner Fischer-Colbrie, et al.
International Journal of Molecular Sciences|June 27, 2024
Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in MelanomaSamantha Lasser, Feyza Gul Ozbay Kurt, Lennart Fritz, et al.
Pageof 49

Showing results (251-260 of 490) with videos related to

Sort By:
Pageof 49
Lancet (London, England)|September 22, 2018
MelanomaDirk Schadendorf, Alexander C J van Akkooi, Carola Berking, et al.
Medical Image Analysis|March 20, 2024
CellViT: Vision Transformers for precise cell segmentation and classificationFabian Hörst, Moritz Rempe, Lukas Heine, et al.
Stem Cell Reports|October 3, 2017
An RNAi Screen Reveals an Essential Role for HIPK4 in Human Skin Epithelial Differentiation from iPSCsLionel Larribère, Marta Galach, Daniel Novak, et al.
International Journal of Cancer|August 15, 2018
A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survivalAdi Sharbi-Yunger, Mareike Grees, Gal Cafri, et al.
Frontiers in Immunology|March 2, 2023
Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patientsVera Petrova, Christopher Groth, Rebekka Bitsch, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 30, 2026
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysisGlenn Geidel, Sabrina Bänsch, Laura Adam, et al.
Ebiomedicine|September 3, 2023
Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma - analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIMJan-Malte Placke, Mona Kimmig, Klaus Griewank, et al.
Frontiers in Immunology|June 25, 2024
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse eventsElias A T Koch, Anne Petzold, Edgar Dippel, et al.
Plos One|February 22, 2014
Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cellsWiebke K Peitsch, Yvette Doerflinger, Reiner Fischer-Colbrie, et al.
International Journal of Molecular Sciences|June 27, 2024
Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in MelanomaSamantha Lasser, Feyza Gul Ozbay Kurt, Lennart Fritz, et al.
Pageof 49